Bone metastasis from prostate cancer
Abstract
Bone metastases are often observed in patients with lung cancer, kidney cancer, breast cancer, myeloma, and prostate cancer. Bone metastases from prostate cancer often show characteristics different from those that originated from other organs : For instance, bone is often the only target organ for prostate cancer metastases, and bone metastatic lesions from prostate cancer are more osteoblastic than osteolytic. It is thought that metastatic prostate cancer cells interact specifically with osseous tissue and that this tissue-specific interaction is a critical factor in cancer progression. An understanding of bone metastasis in prostate cancer may lead to novel treatments against the disease. Here, we present the mechanisms that underlie osteoblastic bone metastasis of prostatic origin.
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.